IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,080 | -14.3% | 23,811 | -22.5% | 0.01% | -14.3% |
| Q2 2023 | $1,260 | +90.3% | 30,711 | +65.9% | 0.01% | +75.0% |
| Q1 2023 | $662 | -5.3% | 18,511 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $699 | -99.9% | 18,511 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $819,000 | +19.6% | 18,511 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $685,000 | +34.8% | 18,511 | +35.0% | 0.00% | +33.3% |
| Q1 2022 | $508,000 | -31.6% | 13,711 | -43.8% | 0.00% | -25.0% |
| Q4 2021 | $743,000 | -9.3% | 24,411 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $819,000 | -15.9% | 24,411 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $974,000 | -5.9% | 24,411 | +6.1% | 0.01% | -16.7% |
| Q1 2021 | $1,035,000 | -31.2% | 23,011 | -13.5% | 0.01% | -33.3% |
| Q4 2020 | $1,505,000 | +42.1% | 26,611 | +19.3% | 0.01% | +12.5% |
| Q3 2020 | $1,059,000 | -59.7% | 22,311 | -50.0% | 0.01% | -27.3% |
| Q2 2020 | $2,630,000 | – | 44,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |